ArticleClinical autonomic research : official journal of the Clinical Autonomic Research Society2026
Baseline peripheral inflammatory profiles predict phenoconversion in prodromal Parkinson's disease: a longitudinal cohort study.
Article in Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAutonomic dysfunction is an early and prognostically important feature of Parkinson's disease, yet accessible biomarkers capturing systemic inflammatory processes potentially linked to autonomic dysfunction during the prodromal phase remain limited. We evaluated whether complete blood count-derived inflammatory indices predict phenoconversion in prodromal Parkinson's disease.
methodsWe conducted a retrospective cohort analysis of 452 prodromal participants from the Parkinson's Progression Markers Initiative. Five complete blood count-derived inflammatory indices-the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, systemic immune-inflammation index, and systemic inflammation response index-were evaluated using Cox proportional hazards models with penalized variable selection, sex-stratified analyses, and internal validation.
resultsDuring follow-up, 43 participants (9.5%) phenoconverted. The systemic inflammation response index showed the strongest and most consistent association with phenoconversion, remaining independently associated after penalized variable selection (hazard ratio 2.34 per log-unit, 95% confidence interval 1.28-4.29; optimism-corrected concordance statistic 0.683; calibration slope 0.864). Effect estimates were larger in male participants, while female estimates were imprecise as a result of limited events; no statistically significant biomarker-by-sex interaction was detected. Longitudinal analyses indicated that baseline inflammatory levels, rather than subsequent changes, carried the primary prognostic signal.
conclusionBaseline systemic inflammation response index derived from routine complete blood counts was associated with phenoconversion risk in prodromal Parkinson's disease, although with a relatively low number of phenoconversion events. External validation of these findings with larger, independent cohorts would further support its utility in peripheral systemic inflammatory conditions such as those observed in autonomic dysfunctions.
Indexed as
Identifiers
42778869What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.